These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 35557589)

  • 1. CCDC68 predicts poor prognosis in patients with colorectal cancer: a study based on TCGA data.
    Zhang W; Xu TT; An ZT; Wei LF; Gu C; Li H; Tian YZ
    J Gastrointest Oncol; 2022 Apr; 13(2):657-671. PubMed ID: 35557589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-3614-5p Is a Potential Novel Biomarker for Colorectal Cancer.
    Han L; Sun Y; Lu C; Ma C; Shi J; Sun D
    Front Genet; 2021; 12():666833. PubMed ID: 34127929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA PCAT6 is a predictor of poor prognosis of colorectal cancer.
    Han L; Li Z; Zhang P; Sheng M; Wang W; Sun Y; Sun D
    J Gastrointest Oncol; 2024 Feb; 15(1):190-202. PubMed ID: 38482211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of NOP58 as a Prognostic Marker in Hepatocellular Carcinoma: A TCGA Data-Based Analysis.
    Wang J; Huang R; Huang Y; Chen Y; Chen F
    Adv Ther; 2021 Jun; 38(6):3342-3361. PubMed ID: 34014550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA MIR4435-2HG predicts poor prognosis in patients with colorectal cancer.
    Ouyang W; Ren L; Liu G; Chi X; Wei H
    PeerJ; 2019; 7():e6683. PubMed ID: 30972258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of LINC02560 in colorectal cancer correlates with tumor microenvironment immunity.
    Luo C; Liu F; Su W; Long P; Liang J; Hou W; Jiang H; Long X; Su G
    J Cancer; 2021; 12(24):7507-7517. PubMed ID: 35003370
    [No Abstract]   [Full Text] [Related]  

  • 7. LncRNA MSC-AS1 Is a Diagnostic Biomarker and Predicts Poor Prognosis in Patients With Gastric Cancer by Integrated Bioinformatics Analysis.
    Yang W; Ge F; Lu S; Shan Z; Peng L; Chai J; Liu H; Li B; Zhang Z; Huang J; Hua Y; Zhang Y
    Front Med (Lausanne); 2021; 8():795427. PubMed ID: 34926534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNA FOXP4-AS1 is a prognostic biomarker and associated with immune infiltrates in ovarian serous cystadenocarcinoma.
    Liao C; Wang A; Ma Y; Liu H
    Medicine (Baltimore); 2021 Oct; 100(40):e27473. PubMed ID: 34622876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of autophagy-related genes for predicting clinical prognosis in colorectal cancer.
    Liu L; Zhang J; Liu H; Shi M; Zhang J; Chen L; Huang L; Li B; Xu P
    Biomark Med; 2021 Jun; 15(10):715-729. PubMed ID: 34169735
    [No Abstract]   [Full Text] [Related]  

  • 10. HTRA3 Is a Prognostic Biomarker and Associated With Immune Infiltrates in Gastric Cancer.
    Ji C; Sun LS; Xing F; Niu N; Gao HL; Dai JW; Zhou N; Jiang BC
    Front Oncol; 2020; 10():603480. PubMed ID: 33425760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ring finger protein 215 is a potential prognostic biomarker involved in immune infiltration and angiogenesis in colorectal cancer.
    Wu JB; Li XJ; Liu H; Liu XP
    Biomed Rep; 2023 Jul; 19(1):50. PubMed ID: 37383678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of LBX2 associated with tumor progression and poor prognosis in colorectal cancer.
    Huang X; Yang Y; Yang C; Li H; Cheng H; Zheng Y
    Oncol Lett; 2020 Jun; 19(6):3751-3760. PubMed ID: 32382328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased expression of RUNX1 in clear cell renal cell carcinoma predicts poor prognosis.
    Fu Y; Sun S; Man X; Kong C
    PeerJ; 2019; 7():e7854. PubMed ID: 31592165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NDUFA4L2 is a novel biomarker for colorectal cancer through bioinformatics analysis.
    Lin Y; Xie H; Zhao W; Li Y; Zhang Z
    Medicine (Baltimore); 2023 Nov; 102(44):e35893. PubMed ID: 37933010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal expression of ABCD3 is an independent prognostic factor for colorectal cancer.
    Zhang Y; Zhang Y; Wang J; Yang J; Yang G
    Oncol Lett; 2020 May; 19(5):3567-3577. PubMed ID: 32269631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased expression of TFAP2B in endometrial cancer predicts poor prognosis: A study based on TCGA data.
    Wu H; Zhang J
    Gynecol Oncol; 2018 Jun; 149(3):592-597. PubMed ID: 29602546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coiled-Coil Domain-Containing 68 Downregulation Promotes Colorectal Cancer Cell Growth by Inhibiting ITCH-Mediated CDK4 Degradation.
    Wang C; Li H; Wu L; Jiao X; Jin Z; Zhu Y; Fang Z; Zhang X; Huang H; Zhao L
    Front Oncol; 2021; 11():668743. PubMed ID: 33968776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased E2F2 predicts poor prognosis in patients with HCC based on TCGA data.
    Zeng Z; Cao Z; Tang Y
    BMC Cancer; 2020 Oct; 20(1):1037. PubMed ID: 33115417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased expression of TXNIP predicts poor prognosis in patients with clear cell renal cell carcinoma.
    Gao Y; Qi JC; Li X; Sun JP; Ji H; Li QH
    Oncol Lett; 2020 Jan; 19(1):763-770. PubMed ID: 31897192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PCGF1 is a prognostic biomarker and correlates with tumor immunity in gliomas.
    Xie J; Qiao L; Deng G; Liang N; Xing L; Zhang J
    Ann Transl Med; 2022 Feb; 10(4):227. PubMed ID: 35280367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.